Progenics Pharmaceuticals, Inc. is a pharmaceutical company that specializes in developing innovative medicines and technologies to target and treat cancer. With a focus on precision diagnostics and radiopharmaceuticals, Progenics aims to improve outcomes and lives. As of now, Progenics is a part of Lantheus company.

Progenics Pharmaceuticals Inc, profile picture · Progenics Pharmaceuticals Inc. Senior Vice-President. July 2005 - September 2012. Pharmaceutical Quality.

The official site for Progenics Pharmaceuticals, Inc. develops innovative medicines and other technologies to target and treat cancer. Nasdaq: PGNX.

Progenics Pharmaceuticals, Inc. | 6653 followers on LinkedIn. Progenics is now a Lantheus company.

Progenics Pharmaceuticals, Inc.

Find contacts at this company